Analysis: Questions over AstraZeneca’s COVID-19 vaccine data risk delaying approval
London (Reuters) – Days after grabbing headlines with its COVID-19 “vaccine for the world”, AstraZeneca is facing tricky questions about
Read MoreLondon (Reuters) – Days after grabbing headlines with its COVID-19 “vaccine for the world”, AstraZeneca is facing tricky questions about
Read Moreby Ashley Rosa Past studies have shown that exercise has a positive effect on a person’s mood. A study containing
Read MoreBrasilia (Reuters) – Vaccinating 20% of the population of Latin America and the Caribbean against COVID-19 will cost more than
Read MoreReuters Pfizer Inc will seek emergency U.S. approval for its COVID-19 vaccine within days after final trial results showed its
Read MoreOttawa (Reuters) – Canada on Wednesday identified state-sponsored programs in China, Russia, Iran and North Korea as major cyber crime
Read MoreBeijing (AFP) – An unidentified Chinese buyer on Sunday paid a world record 1.6 million euros ($1.9 million) for a
Read MoreLondon (Reuters) – French President Emmanuel Macron on Thursday welcomed the prospect of U.S. President-elect Joe Biden rejoining the Paris
Read MoreParis (Reuters) – European officials warned against COVID-19 complacency on Thursday and said measures to control a surge in infections
Read MoreLondon (Reuters) – Measles surged to infect almost 870,000 people across the world in 2019, the worst figures in almost
Read MoreReuters Health experts said Pfizer’s results were positive for all COVID-19 vaccines currently in development… Pfizer Inc PFE.N said on
Read More